| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |